Description
Buy CJC1295 DAC 2mg
CJC-1295, also known as DAC:GRF (short for drug affinity complex:growth hormone-releasing factor). A synthetic analogue of growth hormone-releasing hormone (GHRH) (also known as growth hormone-releasing factor (GRF)) and a growth hormone secretagogue (GHS) which was developed by ConjuChem Biotechnologies.It is a modified form of GHRH (1-29) with improved pharmacokinetics, especially in regard to half-life.
CJC-1295 markedly increases plasma growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels in both animals and humans. A single injection CJC-1295 increases plasma GH levels by 2- to 10-fold for 6 days or longer. Plasma IGF-1 levels by 0.5- to 3-fold for 9 to 11 days. The drug has an estimated half-life of about 6 to 8 days in humans. With multiple doses of CJC-1295, IGF-1 levels were found to remain elevated in humans for up to 28 days.
CJC-1295 w/DAC is a synthetic version of a portion of naturally produced growth hormone releasing hormone. This modified version consists of just the first 29 amino acids of GHRH. As a modified version promotes the production of growth hormone (GH). Some animal and human studies suggest that CJC-1295 w/DAC increased the secretion of GH (growth hormone) while preserving the normal physiological release of GH. The release of these hormones will stimulate bone density, collagen production, production of muscle mass as well as boosting the immune system. CJC-1295 Dac has been shown to extend the half-life and bioavailability of growth-hormone-releasing hormone 1-29 and stimulate insulin-like growth factor 1 secretion. It increases the half-life of acting agents by bioconjugation.
